CJC-1295 is known to cause fluid retention and was associated with a death related to cardiovascular dysfunction in a clinical trial. — Whalespan
CJC-1295 is known to cause fluid retention and was associated with a death related to cardiovascular dysfunction in a clinical trial.
⚠ High risk
We can't find evidence that holds up here. Proponents are reasoning from mechanism or analogy rather than direct human data, and the most credible skeptics raise objections we can't dismiss.
✕NOTSUPPORTED
⚠
High-risk intervention — consult a physician before acting.Drug-drug interactions, dose-dependence, and screening contraindications apply.
“keep in mind that cjc-1295 has entered clinical trials there was a death within one of the clinical trials that was related to cardiovascular dysfunction it's known to cause some fluid retention and increased fluid volume which may have been related to that cardiovascular death”
Video
Conflict Watch
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.